Cobenfy’s efficacy at treating the symptoms of patients with psychosis may vary between subgroups, according to a post-hoc ...

In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...

Newron Pharmaceuticals SpA ( ($CH:NWRN) ) just unveiled an announcement. Newron Pharmaceuticals has announced the US launch of its global Phase ...

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) shares began Tuesday sharply higher. The company today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug ...

Schizophrenia has long been framed as a disorder of broken thoughts and fractured perception, but a new line of research ...

CINCINNATI, Ohio. (Ivanhoe Newswire) --- Schizophrenia - the statistics are terrifying; more than 3.7 million people are living with it right now in the United States. If left untreated it can be ...

Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with ...

A special research fund of 50,000 pounds sterling ($140,000) for studies to promote better understanding, prevention, treatment and cure of schizophrenia was established on behalf of the Rothschild ...

A major scientific review reveals a deep knowledge gap in how cognition is affected when schizophrenia and personality disorders occur together.

Credit: Getty Images Schizophrenia is a type of psychotic disorder that affects how a person thinks and interprets reality. Like schizophrenia, schizoaffective disorder is also a type of psychotic ...

If you have either schizophrenia or psychosis you may experience symptoms like hallucinations or delusions. But although schizophrenia and psychosis have these symptoms in common, the two conditions ...